iCo Therapeutics Inc. announced the appointment of Douglas G. Janzen to iCo's Board of Directors. Mr. Janzen currently serves as President, Chief Executive Officer and a Director of Cardiome Pharma Corp. Mr. Janzen also currently serves as a director of NEOVASC INC. and as a director of various industry trade associations, including Chairman of the board of directors of Life Sciences British Columbia.